“We downgrade the stock to Neutral today, as upside will only materialize in a bull case, in which the outlook beyond 2025 increases materially, and we do not have the conviction on this scenario playing out yet,” said New Street analyst Pierre Ferragu in a report on Friday. The firmContinue Reading
JHVEPhoto The U.S. FDA has granted Inozyme Pharma (NASDAQ:INZY) Fast Track designation for NZ-701, its treatment of ABCC6 Deficiency. The company noted it hopes to have an agreement with regulators on a pivotal trial design by the end of the year. In April, Inozyme released promising topline results from anContinue Reading
Joaquin Corbalan/iStock via Getty Images Lynas Rare Earths (OTCPK:LYSCF) (OTCPK:LYSDY) said Thursday it plans to begin production in 2025 of two separated heavy rare earth products used in electric vehicles and electronic gadgets at its metals processing plant in Malaysia. Lynas (OTCPK:LYSCF) (OTCPK:LYSDY) said it has designed a new processContinue Reading
Apu Gomes/Getty Images News The Internal Revenue Service has apologized to Ken Griffin, billionaire CEO of hedge fund Citadel, as well as thousands of other wealthy Americans whose personal tax information was leaked to the press by a former IRS contractor. Charles Littlejohn, who is serving a five-year prison sentence,Continue Reading
